News
FDA approves first EpiPen generic
The approval is for the generic version of the most widely prescribed epinephrine autoinjector in the United States.
We have updated our Privacy Policy. Please take the time to review
News from the FDA/CDC
Kalydeco approved for patients aged 1-2 years
Kalydeco (ivacaftor) treats the underlying cause of cystic fibrosis and previously was approved for patients aged 2 years and older.
Conference Coverage
App tied to reducing insomnia, depression in adults
ROCKVILLE, MD. – ‘Sleepio,’ an online intervention, could address the shortage of clinicians equipped to use CBT to treat insomnia.
From the Journals
Aggressive drainage regimen may promote spontaneous pleurodesis
The optimal regimen of drainage after an indwelling pleural catheter is placed is a subject of debate.
From the Journals
Low-dose CT fails to improve small cell lung cancer survival
Previous studies on the value and impact of low-dose CT for SCLC diagnosis have been divergent.
Feature
Docs push back on step therapy in Medicare Advantage
The action is part of the broader Trump administration initiative to lower the prices and out-of-pocket costs of prescription drugs.
From the Journals
Lung ultrasound predicts need for first-dose surfactant in neonates
Administering surfactant within the first 2-3 hours of life is key to reducing bronchopulmonary dysplasia and risk of death.
Conference Coverage
French warn of upsurge in pneumococcal meningitis
MALMO, SWEDEN – Culprit is emergence of serotype 24F, not covered by PCV13.
From the Journals
Long-acting beta2 agonists don’t impact cardiovascular risk factors
“These findings, in a large COPD database, speak against the potential negative cardiovascular effects of olodaterol, as well as those of...
From the Journals
Shared decision making falls short for lung cancer screening
Patients tend to overestimate the benefits and underestimate the harms of screening tests.
From the Journals
No increase in autism risk with prenatal Tdap
This study supports the recommendation to vaccinate pregnant women with Tdap to protect infants, who are at highest risk of pertussis.
Feature
CMS pushes ACOs to take on more risk
ACOs that only take on upside risk generally are spending more money and not generating savings, according to CMS Adminstrator Seema Verma.
From the Journals
Secondhand smoke drives ED visits for teens
Teens exposed to secondhand smoke were approximately 1.50 times more likely than were unexposed peers to report missing school because of poor...
Conference Coverage
Treating sleep disorders in chronic opioid users
Continuous-positive airway pressure may not be an effective therapy for patients with sleep disorders who are using opioids.
Conference Coverage
Next-gen sputum PCR panel boosts CAP diagnostics
NEW ORLEANS – The BioFire film array panel is now before the FDA.
From the Journals
Broad genomic testing of NSCLC in community oncology disappoints
Among patients with advanced NSCLC treated in community oncology practices, broad-based genomic sequencing seldom exclusively informed the...
News
Doctors decry inaction on physician-focused APMs
So far, PTAC has sent at least 10 APMs to the CMS. To date, not a single one has been approved or even tested on a limited scale.
Feature
COPD opposites: Utah and West Virginia
Prevalence estimates from the American Lung Association rank the states first and 51st.
From the Journals
RSV-related risk of hospitalization higher in Down syndrome patients
Rates are higher for hospital and ICU admission, mortality, length of stay, supplemental oxygen, and ventilator support.
News from the FDA/CDC
FDA gives Orkambi indication for younger patients
Previously, the drug was indicated for certain cystic fibrosis patients aged 6 years and older, but now it is available for patients as young as 2...
From the Journals
Score predicts 3-month mortality in malignant pleural effusion
A combination of biomarkers and clinical markers could be used to predict 3-month mortality and treatment response in malignant pleural effusion...
News From CHEST
Clinician educator opportunities at CHEST 2018
At CHEST 2018, you will be offered more than 25 hours of content focused on enhancing your teaching.
News from CHEST
-
Restaurants galore at CHEST 2018 -
-
Clinician educator opportunities at CHEST 2018 -
CHEST NetWorks -
-
CHEST 2018 postgrad courses – incredible learning opportunities -
New opportunity for CHEST Foundation -
-
Explore Ultrasound Corner -
Launching the Moderate to Severe Asthma Center of Excellence
Practice Management
- Docs push back on step therapy in Medicare Advantage
- CMS pushes ACOs to take on more risk
- Broad genomic testing of NSCLC in community oncology disappoints
- Doctors decry inaction on physician-focused APMs
- Ranked: State of the states’ health care
- Some doctors are warming to single-payer medicine
- CMS proposal to level E/M payments raises concerns
- PhRMA spending leads health-sector lobbying efforts
- To tame prescription prices, HHS dips a toe into drug importation stream
- CMS to resume risk adjustment payments for 2017
